Cleveland Ohio based Diasome Pharmaceuticals is raising $2,897,788.00 in New Equity Investment.
Cleveland, OH – According to filings with the U.S. Securities and Exchange Commission, Diasome Pharmaceuticals is raising $2,897,788.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Robert Geho played a…